ECDC - Coronavirus disease 2019 (COVID-19) and supply of substances of human origin in the EU/EEA - Second update

ECDC - Coronavirus disease 2019 (COVID-19) and supply of substances of human origin in the EU/EEA - Second update

European Centre for Disease Prevention and ControlThis second update of the original document integrates the experience of maintaining safe and sufficient supply of substances of human origin (SoHO) gained in the course of the COVID-19 pandemic...
ECDC - Rapid Risk Assessment: Risk of COVID-19 transmission related to the end-of-year festive season

ECDC - Rapid Risk Assessment: Risk of COVID-19 transmission related to the end-of-year festive season

European Centre for Disease Prevention and ControlAfter a scale-up of non-pharmaceutical interventions implemented by several Member Sates starting from the end of October, a recent overall decreasing trend in the 14-day COVID-19 notification...
WHO - Draft landscape of COVID-19 candidate vaccines – 26 November 2020

WHO - Draft landscape of COVID-19 candidate vaccines – 26 November 2020

World Health OrganizationThese landscape documents have been prepared by the World Health Organization (WHO) for information purposes only concerning the 2019-2020 global of the novel coronavirus. Inclusion of any particular product or entity in...
NEJM - Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

NEJM - Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

The New England Journal of MedicineWorld Health Organization expert groups recommended mortality trials of four repurposed antiviral drugs — remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a — in patients hospitalized with...
NEJM - Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

NEJM - Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

The New England Journal of MedicineWe recently reported the results of a phase 1 trial of a messenger RNA vaccine, mRNA-1273, to prevent infection with SARS-CoV-2; those interim results covered a period of 57 days after the first vaccination.
WHO - Mask use in the context of COVID-19

WHO - Mask use in the context of COVID-19

World Health OrganizationThis document provides updated guidance on mask use in health care and community settings, and during home care for COVID-19 cases. It is intended for policy makers, public health and infection prevention and control...
ECDC - Updated projections of COVID-19 in the EU/EEA and the UK

ECDC - Updated projections of COVID-19 in the EU/EEA and the UK

European Centre for Disease Prevention and ControlFollowing widespread transmission of SARS-CoV-2 in the European Union (EU)/European Economic Area (EEA) countries and the United Kingdom (UK) over several weeks, the COVID-19 epidemic reached a...
ECDC - Contact tracing: public health management of persons, including healthcare workers, who have had contact with COVID-19 cases in the European Union – third update

ECDC - Contact tracing: public health management of persons, including healthcare workers, who have had contact with COVID-19 cases in the European Union – third update

European Centre for Disease Prevention and ControlThis document aims to help public health authorities in EU/EEA countries and the UK in their tracing and management of persons, including healthcare workers, who have had contact with COVID-19...
WHO - Therapeutics and COVID-19: living guideline

WHO - Therapeutics and COVID-19: living guideline

World Health OrganizationCurrent practice to treat COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized controlled trials (RCTs) of many different drugs are underway to inform practice. This version of the World Health...
WHO - Priority medical devices list for the COVID-19 response and associated technical specifications

WHO - Priority medical devices list for the COVID-19 response and associated technical specifications

World Health OrganizationThis document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. 
ECDC - Options for the use of rapid antigen tests for COVID-19 in the EU/EEA and the UK

ECDC - Options for the use of rapid antigen tests for COVID-19 in the EU/EEA and the UK

European Centre for Disease Prevention and ControlRapid antigen tests can contribute to overall COVID-19 testing capacity, offering advantages in terms of shorter turnaround times and reduced costs, especially in situations in which RT-PCR...
ECDC - Rapid Risk Assessment: Increase in fatal cases of COVID-19 among long-term care facility residents in the EU/EEA and the UK

ECDC - Rapid Risk Assessment: Increase in fatal cases of COVID-19 among long-term care facility residents in the EU/EEA and the UK

European Centre for Disease Prevention and ControlObserved all-cause mortality among older people underlines the severe impact of COVID-19 in this population group. Residents in long-term care facilities (LTCFs) are one of the most vulnerable...
WHO - Technical specifications of personal protective equipment for COVID-19

WHO - Technical specifications of personal protective equipment for COVID-19

World Health OrganizationThis document provides interim guidance on the quality, performance characteristics and related standards of personal protective equipment (PPE) to be used in the context of COVID-19. This includes WHO Priority Medical...
WHO - Guidance on developing a national deployment and vaccination Planning for COVID-19 vaccines

WHO - Guidance on developing a national deployment and vaccination Planning for COVID-19 vaccines

World Health Organization

The Guidance on National Deployment and Vaccination Planning is intended to help countries develop their plan for COVID-19 vaccine introduction.

ECDC - Heating, ventilation and air-conditioning systems in the context of COVID-19: first update

ECDC - Heating, ventilation and air-conditioning systems in the context of COVID-19: first update

European Centre for Disease Prevention and Control
This document provides guidance on heating, ventilation and air-conditioning (HVAC) systems in closed spaces in the context of the COVID-19 pandemic.
123468910Último
Categorias

Categorias

Arquivo de Notícias

Arquivo